Introduction
renal and cardiovascular diseases, diabetes
DIABETES
Edited by: Åke Sjöholm, Gävle Hospital, SwedenReviewed by: Miliani Maroua, University of Abou Bekr Belkaïd Tlemcen, Algeria; Fatima O. Martins, New University of Lisbon, PortugalThe ratio between advanced glycation end products (AGEs) and soluble form of receptor (s-RAGE) has been proposed as a risk marker for renal and cardiovascular diseases. The aim of this study was to evaluate in the diabetes condition the influence of two different oral anti-diabetic treatments on the AGE/s-RAGE ratio, during a 5-year observation period.